In conclusion, serum anti-AQP5 levels significantly increased in pSS patients, with a sensitivity of 0.95 and a specificity of 0.70, indicating that anti-AQP5 is a novel diagnostic biomarker for pSS. The gene discussed is AQP5; the disease is peeling skin syndrome.